NOAH Compendium

Printed from NOAH Compendium (https://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2024. All Rights Reserved.
Date: Tuesday, May 7, 2024 9:50

Release 3.341
Imidaflea Spot-on Solution for Cats, Pet Rabbits and Dogs
 
Species: Cats, Dogs, Rabbits
Therapeutic indication: Pharmaceuticals: Ectoparasiticides: For dogs, For cats, For rabbits
Active ingredient: Imidacloprid
Product:Imidaflea Spot-on Solution for Cats, Pet Rabbits and Dogs
Product index: Imidaflea Spot-on Solution for Cats, Pet Rabbits and Dogs
Withdrawal notes: Do not use on rabbits intended for human consumption
Incorporating:
Presentation
Each 1 ml contains:
Active substance:
Imidacloprid 40 mg/80 mg/100 mg/250 mg/400 mg
Excipients:
Butylhydroxytoluene (E 321) 0.4 mg/0.8 mg/1.0 mg/2.5 mg/4.0 mg
Clear yellow to slightly brownish solution.
Uses
Cats & Pet Rabbits
Prevention and treatment of flea (Ctenocephalides felis) infestations in cats of less than 4 kg bodyweight and 4 kg bodyweight and greater.
Treatment of flea infestations in rabbits of less than 4 kg body weight and 4 kg bodyweight and greater.
Fleas are killed within one day following treatment. One treatment prevents further flea infestation for three to four weeks on cats and up to one week on pet rabbits.
Dogs
For the prevention and treatment of flea infestations and for the treatment of biting lice (Trichodectes canis) on dogs of less than 4 kg body weight/4 kg to less than 10 kg body weight/10 kg to less than 25 kg body weigh/25 kg body weight and greater. Fleas on dogs are killed within one day following treatment. One treatment prevents further flea infestation for four weeks
Dosage and administration
This product is for external use only and should not be administered orally. Animals should be weighed accurately prior to treatment.
Dosage and Treatment Schedule
Imidaflea 40 mg for Small Cats, Small Pet Rabbits and Small Dogs < 4 kg - 1 x 0.4 ml
Imidaflea 80 mg for Large Cats and Large Pet Rabbits ≥ 4 kg - 1 x 0.8 ml
Imidaflea 100 mg for Dogs ≥ 4 to < 10 kg - 1 x 1.0 ml
Imidaflea 250 mg for Dogs ≥ 10 to < 25 kg - 1 x 2.5 ml
Imidaflea 400 mg for Dogs ≥ 25 to < 40 kg - 1 x 4.0 ml
Imidaflea 400 mg for Dogs ≥ 40 kg - 2 x 4.0 ml
In cases of biting louse infestation, a further veterinary examination 30 days after treatment is recommended as some animals may require a second treatment.
Method of administration:
Cat and rabbits
Hold the pipette upright. Tap the narrow part of the pipette to ensure the contents remain within the main body of the pipette. Snap back the tip. Part the hair on the animal’s neck at the base of the skull until the skin is visible.
Place the tip of the pipette on the skin and squeeze the pipette several times to empty its contents completely and directly onto the skin in one spot. Correct application will minimise the opportunity for the animal to lick the product.
Dogs
Hold the pipette upright. Tap the narrow part of the pipette to ensure the contents remain within the main body of the pipette. Snap back the tip. With the dog in the standing position, part the coat between the shoulder blades until the skin is visible. Place the tip of the pipette on the skin and squeeze the pipette several times to empty its contents completely and directly onto the skin in one spot. Correct application will minimise the opportunity for the animal to lick the product.
Contra-indications, warnings, etc
Contraindications
Cats & Pet Rabbits
Do not treat unweaned kittens of less than 8 weeks of age.
Do not use on pet rabbits of less than 10 weeks of age.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Dogs
Do not treat unweaned puppies of less than 8 weeks of age.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Special warnings for each target species
If signs of disease persist or appear, consult a veterinary surgeon.
Re-infestation from emergence of new fleas in the environment may continue to occur for six weeks or longer after treatment is initiated. More than one treatment may therefore be required, depending on the level of fleas in the environment. To aid reduction in environmental challenge, the additional use of a suitable environmental treatment against adult fleas and their developing stages is recommended. In order to reduce further the environmental challenge, it is recommended that all cats, dogs and rabbits in the household are treated.
The product remains effective if the animal becomes wet, for example after exposure to heavy rain. However, re-treatment may become necessary, depending on the presence of fleas in the environment. In these cases do not treat more frequently than once weekly.
Special precautions for use
Special precautions for use in animals
This product is for topical use and should not be administered orally.
Apply only to undamaged skin
Care should be taken to avoid the contents of the pipette coming into contact with the eyes or mouth of the recipient animal.
Do not allow recently treated animals to groom each other.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
This product can cause mucous membrane, skin and eye irritation.
Therefore, contact of the product with mouth, skin and eyes should be avoided.
This product contains benzyl alcohol and may cause skin sensitisation or transient skin reactions in rare cases (for example, irritation, tingling).
People with a known hypersensitivity (allergy) to insecticides or alcohol should avoid contact with the product.
Do not smoke, drink or eat during application.
If contact with the skin occurs, wash hands with soap and water.
If the product gets into eyes, the eyes should be thoroughly rinsed with clean water. If skin or eye irritation persists, or the product is accidentally swallowed, seek medical advice.
Do not stroke, groom or play with treated animals until the application site is dry. It is therefore recommended that animals are not treated during the day, but should be treated during the early evening, and that recently treated animals are not allowed to sleep with owners, especially children.
Dispose of used pipettes immediately.
Wash hands after use.
Other precautions
The solvent in this product may stain certain materials including leather, fabrics, plastics and finished surfaces. Allow the application site to dry before permitting contact with such materials.
Imidacloprid is toxic to aquatic organisms. To avoid adverse effects on aquatic organisms, treated dogs should not be allowed to enter surface water for 48 hours after treatment.
Adverse reactions (frequency and seriousness)
The product is bitter tasting and salivation may occasionally occur if the animal licks the application site immediately after treatment. This is not a sign of intoxication and disap­pears within some minutes without treatment.
In very rare occasions (less than 1 animal in 10,000 animals, including isolated reports) skin reactions such as hair loss, redness, itching and skin lesions may occur. Agitation has also been reported. Excessive salivation and nervous signs such as incoordination, tremors and depression have been reported but exceptionally in cats/dogs.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Use during pregnancy, lactation or lay
No reproductive toxic effects have been observed in rats and no primary embryotoxic or teratogenic toxic effects have been observed during the studies on rats and rabbits. Studies on pregnant and lactating bitches, queens and does together with their offspring are limited. Evidence so far suggests that no adverse effects are to be expected in these animals. Consult your veterinary surgeon before using in pregnant or nursing animals.
Interaction with other medicinal products and other forms of interaction
Do not use simultaneously with other flea products which are applied directly onto the animal.
Pharmaceutical precautions
Major incompatibilities
None known.
Special precautions for storage
This veterinary medicinal product does not require any special storage conditions.
Legal category
Legal category: AVM-GSL
Packaging quantities
A white pipette composed of a heat-formed shell of composed of a polypropylene/cyclic olefin copolymer/polypropylene layer and a polyethylene/ethylene vinyl alcohol/polyethylene layer.
Box with 1, 2, 3, 4, 6 pipettes in individual foil sachets. Not all pack sizes may be marketed
Marketing Authorisation Holder (if different from distributor)
EU Pharmaceuticals Ltd., 37 Geraldine Road, London, SW18 2NR
Further information
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements. Imidacloprid may adversely affect aquatic organisms. Do not contaminate ponds, waterways or ditches with the product or empty containers.
Marketing Authorisation Number
Imidaflea 40 mg Spot-on - Vm 39787/4075
Imidaflea 80 mg Spot-on - Vm 39787/4076
Imidaflea 100 mg Spot-on - Vm 39787/4077
Imidaflea 250 mg Spot-on - Vm 39787/4078
Imidaflea 400 mg Spot-on - Vm 39787/4079
Significant changes
GTIN
GTIN description:- -
GTIN:- -